Marca AL, Volpe A. Anti-Müllerian hormone (AMH) in female reproduction: is measurement of circulating AMH a useful tool? Clin Endocrinol. 2006;64(6):603-610. doi:10.1111/j.1365-2265.2006.02533.x

Dumont A, Robin G, Catteau-Jonard S, Dewailly D. Role of Anti-Müllerian Hormone in pathophysiology, diagnosis and treatment of Polycystic Ovary Syndrome: a review. Reprod Biol Endocrinol. 2015;13(1):137. doi:10.1186/s12958-015-0134-9

Kuohung W, Hornstein MD. Evaluation of female infertility – UpToDate. LINK . Accessed August 19, 2020.

Tal R, Seifer DB. Ovarian reserve testing: a user’s guide. Am J Obstet Gynecol. 2017;217(2):129-140. doi:10.1016/j.ajog.2017.02.027

Dewailly D, Andersen CY, Balen A, et al. The physiology and clinical utility of anti-Müllerian hormone in women. Hum Reprod Update. 2014;20(3):370-385. doi:10.1093/humupd/dmt062

ESHRE Capri Workshop Group. Fertility and ageing. Hum Reprod Update. 2005;11(3):261-276. doi:10.1093/humupd/dmi006

Kallen AN, Stovall DW. The Use of Antimüllerian Hormone in Women Not Seeking Fertility Care. ACOG Committee opinion. 2019;133(4):5.

Committee Opinion No. 618: Ovarian Reserve Testing. Obstet Gynecol. 2015;125(1):268–273. doi:10.1097/01.AOG.0000459864.68372.ec

Practice Committee of the American Society for Reproductive Medicine. Testing and interpreting measures of ovarian reserve: a committee opinion. Fertil Steril. 2015;103(3):e9-e17. doi:10.1016/j.fertnstert.2014.12.093

Practice Committee of the American Society for Reproductive Medicine. Diagnostic evaluation of the infertile female: a committee opinion. Fertil Steril. 2015;103(6):e44-e50. doi:10.1016/j.fertnstert.2015.03.019

Barbieri RL. Steroid hormone metabolism in polycystic ovary syndrome – UpToDate. LINK. Accessed August 27, 2020.

Patel N, Zafar Gondal A. Embryology, Mullerian-inhibiting Factor. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2020. http://www.ncbi.nlm.nih.gov/books/NBK544351/. Accessed September 1, 2020.